Absci announces pricing of public offering of common stock

Vancouver, wash., feb. 27, 2024 (globe newswire) -- absci corporation (nasdaq: absi) (“absci”), a data-first generative ai drug creation company, today announced the pricing of an underwritten public offering of 16,700,000 shares of its common stock at a public offering price of $4.50 per share, before deducting underwriting discounts and commissions. in addition, absci has granted the underwriters a 30-day option to purchase up to an additional 2,505,000 shares of its common stock on the same terms and conditions. the gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be approximately $75.2 million, excluding any exercise of the underwriters' option to purchase additional shares. all of the shares in the offering are to be sold by absci.
ABSI Ratings Summary
ABSI Quant Ranking